Pervasive Developmental Disorders and GABAergic System in Patients With Inverted Duplicated Chromosome 15

Abstract

Pervasive developmental disorders are characterized by severe, pervasive impairment in several areas of development, with distorted communication skills and stereotypical behavior. Pervasive developmental disorders have a heterogeneous etiology related to brain damage, familial affective psychopathology, chromosomal abnormalities, or dysfunction of neuromodulators. Recently, it has been suggested that the GABRB3 gene, located within chromosome 15q11-13, is a candidate for pervasive developmental disorder. In inverted duplicated chromosome 15 syndrome, in which there is a small marker chromosome derived from inversion and duplication of the chromosome 15q11-q13 region, all patients present with pervasive developmental disorder. To further investigate a possible involvement of the γ-aminobutyoic acid (GABA)ergic system in the inverted duplicated chromosome 15 syndrome, we evaluated plasma levels of GABA and diazepam binding inhibitor in 6 patients with inverted duplicated chromosome 15 and in 8 subjects not affected by neurologic disease. Our findings do not seem to support this hypothesis as no significant differences were found in the GABA and diazepam binding inhibitor plasma levels between patients with inverted duplicated chromosome 15 and controls, but we must consider the possibility that a genetic abnormality of the GABA_A receptor could be present in patients with inverted duplicated chromosome 15 and still not be reflected in an alteration in either GABA or diazepam binding inhibitor levels in plasma. (J Child Neurol 2001;16:911-914).

Get full access to this article

View all access options for this article.

References

American Psychiatric Association : Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC, American Psychiatric Press, 1994.

DeLong GR : Autism: New data suggest a new hypothesis. Neurology 1999;52:911-916.

Cook EH , Courchesne RY , Cox NJ , et al: Linkage-disequilibrium mapping of autistic disorder, with 15q11-13 markers. Am J Hum Genet 1998;62:1077-1083.

Wandstrat AE , Leana-Cox J. , Jenkins L. , Schwartz S. : Molecular cytogenetic evidence for a common breakpoint in the largest inverted duplications of chromosome 15. Am J Hum Genet 1998;62:925-936.

Borgatti R. , Piccinelli P. , Passoni D. , et al: The relationship between clinical and genetic features in "inverted duplicated chromosome 15" patients. Pediatr Neurol 2001;24:111-116.

Ferrarese C. , Vaccarino F. , Alho H. , et al: Subcellular location and neuronal release of diazepam binding inhibitor (DBI). J Neurochem 1987;48:1093-1102.

Guidotti A. , Forchetti CM , Corda MG , et al: Isolation, characterization and purification to homogeneity of an endogenous polypeptide with agonist action on benzodiazepine receptors . Proc Natl Acad Sci U S A 1983;80:3535-3581.

Guidotti A. , Berkovich A. , Ferrarese C. , et al: Neuronal-glial differential processing of DBI to yield ligands to central or peripheral benzodiazepine recognition sites, in Imidazopyridines in Sleep Disorders. New York, Raven Press, 1988, 25-38.

Vezzani A. , Serafmi R. , Stasi MA , et al: Epileptogenic activity of two peptides derived from diazepam binding inhibitor after intrahippocampal injection in rats. Epilepsia 1991;32:597-603.

10.

Ferrarese C. , Cogliati T. , Tortorella R. , et al: Diazepam binding inhibitor (DBI) in the plasma of paediatric and adult epileptic patients. Epilepsy Res 1998;29:129-134.

11.

Rapin T. Autism in search of a home in the brain. Neurology 1999;52:902-904.

12.

Grammatico P. , Di Rosa C. , Roccella M. , et al: Inv dup(15): Contribution to the clinical definition of the phenotype. Clin Genet 1994 ;46:233-237.

13.

Flejter WL , Bennet-Baker PE , Ghaziuddin M. , et al: Cytogenetic and molecular analysis of inv dup(15) chromosomes observed in two patients with autistic disorder and mental retardation. Am J Hum Genet 1996;61:182-187.

14.

Mignon C. , Malzac P. , Moncla A. , et al: Clinical heterogeneity in 16 patients with inv dup 15 chromosome: Cytogenetic and molecular studies, search for an imprinting effect. Eur J Hum Genet 1996;4:88-100.

15.

Browne CE , Dennis NR , Maher E. , et al: Inherited interstitial duplications of proximal 15q:genotype-phenotype correlations. Am J Hum Genet 1997;61:1342-1352.

16.

Woods CG , Robinson M. , Gardiner C. , Roussounis T. : Four cases of the condition described by Bundey with autism and maternal 15q11-13 duplication. Am J Hum Genet 1997;61:A117.

17.

Schroer RJ , Phelan MC , Michaelis RC , et al: Autism and maternally derived aberrations of chromosome 15q . Am J Med Genet 1998;76:327-336.

18.

Repetto GM , White LM , Bader PJ , et al: Interstitial duplications of chromosome region 15q11q13: Clinical and molecular characterization. Am J Med Genet 1998;79:82-89.

19.

Nakatsu Y. , Tyndale RF , DeLorey TM , et al: A cluster of three GABAA receptor subunit genes is deleted in a neurological mutant of the mouse p locus. Nature 1993;364:448-450.

20.

Battaglia A. , Gurrieri F. , Bertini E. , et al: The inv dup(15) syndrome: A clinically recognizable syndrome with altered behavior, mental retardation, and epilepsy . Neurology 1997 ;48:1081-1086.

21.

Uhlhaas S. , Lange H. , Wappenschmidt J. , et al. Free and conjugated CSF and plasma GABA in Huntington's chorea . Acta Neurol Scand 1986;74:261-265.

22.

Petty F. , Kramer GL , Fulton M. , et al: Low plasma GABA is a trait-like marker of bipolar illness. Neuropsychopharmacology 1993;9:125-132.

23.

Besman MJ , Yanagibashi K. , Lee TD , et al: Identification of des-(Gly-Ile)-endozepine as an effector of corticotropin-dependent adrenal steroidogenesis: Stimulation of cholesterol delivery is mediated by the peripheral benzodiazepine receptor. Proc Natl Acad Sci U S A 1989;86:4897-4901.

24.

Loscher W. , Gram L. , Stefan H. : Plasma GABA and seizure control with vigabatrin. Lancet 1993;341:117.